Showing results (151-160 of 366) with videos related to
Sort By:
Pageof 37
Journal of the National Cancer Institute|March 13, 2018
Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 MutationSusana Cedrés, Enriqueta Felip, Cristina Cruz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2025
Taletrectinib in ROS1+ Non-Small Cell Lung Cancer: TRUSTMaurice Pérol, Wei Li, Nathan A Pennell, et al.Nature Medicine|May 5, 2015
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790MKenneth S Thress, Cloud P Paweletz, Enriqueta Felip, et al.Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 studyShirish Gadgeel, Glenwood Goss, Jean-Charles Soria, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2019
Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLCFabrice Barlesi, Edward B Garon, Dong-Wan Kim, et al.JTO Clinical and Research Reports|January 26, 2026
Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 TrialNiels Reinmuth, Sébastien Couraud, Luis Paz-Ares, et al.Anticancer Research|December 7, 2016
Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07Dolores Isla, Enriqueta Felip, Nuria Viñolas, et al.ESMO Open|August 20, 2019
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancerJuan-Miguel Cejalvo, Wolfgang Jacob, Tania Fleitas Kanonnikoff, et al.Oral Oncology|March 29, 2023
Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patientsAlberto Hernando-Calvo, Oriol Mirallas, David Marmolejo, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 17, 2020
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 TrialLuis Paz-Ares, Tae Min Kim, David Vicente, et al.Pageof 37